RD
Therapeutic Areas
BioLineRx Pipeline
| Drug | Indication | Phase |
|---|---|---|
| GLIX1 | Glioblastoma, Other Solid Tumors | Phase 1 |
| Motixafortide | Metastatic Pancreatic Cancer (1st line) | Phase 2b |
Leadership Team at BioLineRx
PA
Philip A. Serlin
Chief Executive Officer
MZ
Mali Zeevi
Chief Financial Officer
ES
Ella Sorani
Chief Development Officer
JB
Jael Birenberg
Vice President, Regulatory Affairs, Quality Assurance & Pharmacovigilance
IG
Irit Gliko-Kabir
Vice President, Clinical Operations
EH
Efrat Halbfinger
Vice President, Chemistry and Formulation
BN
Bela Neiman
Vice President, Analytical Chemistry
AS
Aharon Schwartz
Chairman of the Board
BB
BJ Bormann
Board Member
GC
Gal Cohen
Board Member